These effects on neuronal survival were accompanied by changes in synapse number, cognition, and amyloid and tau pathology, revealing a new potential mechanism underlying the accelerated AD pathogenesis in women during menopause, providing another potential therapeutic target. The gene discussed is MAPT; the disease is Alzheimer disease.